A 25-year-old woman with vitiligo universalis, a severe form of vitiligo that causes nearly complete loss of skin color ...

The panelist discusses how emerging targeted therapies like Janus kinase inhibitors and combination treatment approaches are ...

Roche’s Evrysdi (risdiplam) is the market leader among the drugs for spinal muscular atrophy (SMA). Biogen’s Spinraza ...

As novel gene therapies emerge, there is a complex interplay among their potential benefits, the burdens they may impose and ...

Monjuvi is available under an accelerated approval to treat adults with relapsed or refractory diffuse large B-cell lymphoma.

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

Breast cancer treatment settings prove to be a good opportunity to talk about financial toxicity. These conversations can ...

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

The panelist discusses how intracytoplasmic sperm injection can be used in conjunction with in vitro fertilization (IVF) to ...

Kenan R. Omurtag, M.D., discusses how less invasive fertility treatments like lifestyle modifications, ovulation induction ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...